diclofenac sodium 75 MG Delayed Release Oral Tablet
diclofenac sodium
RxCUI: 855926
What the CMS Formulary Data Shows for diclofenac sodium 75 MG Delayed Release Oral Tablet
Per the CMS 2026 Part D formulary file, diclofenac sodium 75 MG Delayed Release Oral Tablet (RxNorm concept RXCUI 855926, generic name diclofenac sodium) appears on 328 distinct formulary files spanning 5,036 Medicare Part D plan offerings - 99.4% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 3, with a cross-plan average of Tier 1.7.
Real-world access to diclofenac sodium 75 MG Delayed Release Oral Tablet depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 39.3% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,196,668 Part D beneficiaries filled diclofenac sodium 75 MG Delayed Release Oral Tablet in 2023, with total plan-and-beneficiary spending of $396,080,706 and an average per-beneficiary annual cost of $123.90. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry diclofenac sodium 75 MG Delayed Release Oral Tablet today.
Coverage Details
- Formularies covering
- 328
- Plans covering
- 5,036
- Coverage rate
- 99.4%
- Tier range
- Tier 1 – Tier 3
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 39.3% of formularies
2023 Medicare Spending
- Beneficiaries
- 3,196,668
- Total spending
- $396,080,706
- Avg per beneficiary
- $123.90
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering diclofenac sodium 75 MG Delayed Release Oral Tablet
5 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| Anthem Full Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (PPO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Kidney Care (HMO-POS C-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Full Dual Advantage Select (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
| Anthem Dual Advantage (HMO D-SNP) | ANTHEM HEALTH PLANS, INC. | T1 | No | No | $0 | CT |
Medicare Advantage Plans (MA-PD) Covering diclofenac sodium 75 MG Delayed Release Oral Tablet
95 Medicare Advantage plans with Part D drug coverage include this drug.
Frequently Asked Questions
Is diclofenac sodium 75 MG Delayed Release Oral Tablet covered by Medicare Part D?
Yes, diclofenac sodium 75 MG Delayed Release Oral Tablet is covered by 5,036 Medicare Part D plans (99.4% of all Part D formularies).
What tier is diclofenac sodium 75 MG Delayed Release Oral Tablet on Medicare Part D plans?
diclofenac sodium 75 MG Delayed Release Oral Tablet averages Tier 1.7 across Part D plans, ranging from Tier 1 to Tier 3.
Does diclofenac sodium 75 MG Delayed Release Oral Tablet require prior authorization?
0% of Part D formularies require prior authorization for diclofenac sodium 75 MG Delayed Release Oral Tablet. Step therapy: 0%. Quantity limits: 39.3%.
How much does Medicare spend on diclofenac sodium 75 MG Delayed Release Oral Tablet?
In 2023, total Medicare Part D spending on diclofenac sodium 75 MG Delayed Release Oral Tablet was $396,080,706, covering 3,196,668 beneficiaries. The average spend per beneficiary was $123.90.
Read our methodology - how this data is sourced, computed, and verified.